AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Tarsus Pharmaceuticals, Inc. Director's Dealing 2021

Jan 21, 2021

31511_dirs_2021-01-21_c58e0230-2c2f-454c-b97f-62e1d606247c.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Tarsus Pharmaceuticals, Inc. (TARS)
CIK: 0001819790
Period of Report: 2021-01-19

Reporting Person: Wahl Bryan (General Counsel)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	5000	Direct